FDA Brief

Warning letters Devices

FDA warning letter to

AMCO International Manufacturing & Design, Inc.

High riskIssued Jun 25, 2024Posted Jul 30, 2024Center for Devices and Radiological Health

AMCO International made and sold AED replacement batteries without required FDA approval, FDA says.

What happened

FDA inspected AMCO International's Brooklyn, NY facility from March 11, 2024, through March 20, 2024. The investigator found the firm manufactures replacement batteries used in AEDs, including AM9146-2, AM5070, and AM1000. FDA determined the firm had not submitted a required premarket approval (PMA) application by February 3, 2022, and continued to manufacture and distribute the batteries after that date.

What FDA found

  1. AMCO made and distributed AED replacement batteries that require premarket approval without an approved application.

    section 501(f)(1)(A) of the Act, 21 U.S.C. § 351(f)(1)(A)
  2. AMCO did not submit a premarket approval application for AM9146-2, AM5070, and AM1000 by the February 3, 2022, compliance date.

    section 515(b) of the Act, 21 U.S.C. § 360e(b); 21 CFR 870.5310
  3. AMCO continued to manufacture and distribute those batteries after the compliance date.

    section 501(f)(1)(A) of the Act, 21 U.S.C. § 351(f)(1)(A)
  4. AMCO also made and distributed 5L318, 6L785, 5L500, and AM9141 batteries for discontinued AEDs after the compliance date.

    section 515(b) of the Act, 21 U.S.C. § 360e(b)

What FDA wants

FDA asks AMCO to stop activities that adulterate necessary AED accessories and to respond in writing within 15 business days with the steps taken, corrective actions, and a plan to prevent recurrence.

Who should pay attention

  • AED manufacturers whose devices use these batteries
  • distributors and resellers of AED accessories
  • regulatory teams tracking PMA status for device accessories

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Next Medical Products Company, LLC

    FDA warns Next Medical Products that its ultrasound gels were contaminated and made without required quality controls or clearance.

    High risk
  2. Peter Schiff Enterprises

    FDA warns Peter Schiff Enterprises over unapproved cardiac devices and serious quality system failures.

    High risk
  3. Pro-Optics, LLC

    FDA warned Pro-Optics about unapproved material and color changes to contact lens cases and quality system failures.

    Medium
  4. Tides Medical LLC

    FDA warns Tides Medical over APLICOR 3D wound device sold without approval, exemption, or required FDA notice.

    High risk